NCT00082173View on ClinicalTrials.gov

Moxifloxacin As Part of a Multi-Drug Regimen For Tuberculosis

PHASE2CompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2008

Conditions
Tuberculosis
Interventions
DRUG

Moxifloxacin

400mg daily for 8 weeks

Trial Locations (1)

Unknown

Clementino Fraga Filho Hospital, Rio de Janeiro

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT00082173 - Moxifloxacin As Part of a Multi-Drug Regimen For Tuberculosis | Biotech Hunter | Biotech Hunter